Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 12 holding rows worth $110,354,745.

Accession
0001645721-23-000012
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 12 entries on the cover page, a total value of $110,354,745 stated on the cover page (in dollars after the unit check, H1), rows summing to $110,354,745 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARROWHEAD PHARMACEUTICALS IN04280A100COM908,474$24,410,696dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM379,090$19,037,900dollars as filed
REGENXBIO INC75901B107COM847,424$13,948,599dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS1,312,233$12,886,128dollars as filed
KYMERA THERAPEUTICS INC501575104COM782,219$10,872,844dollars as filed
MERUS N VN5749R100COM430,109$10,141,970dollars as filed
ARVINAS INC04335A105COM489,153$9,606,965dollars as filed
C4 THERAPEUTICS INC12529R107COM STK1,990,334$3,702,021dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share52,148$1,839,260dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR3,715$1,826,405dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM88,875$1,097,606dollars as filed
PIERIS PHARMACEUTICALS INC720795103COM3,303,190$984,351dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001645721-23-000012this filing2023-11-14acceptance time not in the bulk data set